Since January 1, 2023, there have been a total of 12,569 suspected Mpox cases, including 581 suspected Mpox deaths (case fatality ratio: 4.6%), reported in the Democratic Republic of Congo (DRC).
The National Emerging Special Pathogens Training and Education Center (NETEC) offers support for U.S. health care agencies that encounter, or may encounter, a case of Mpox virus infection with free, ongoing guidance and resources. NETEC experts are available to provide free consultations and technical support services through NETEC’s online service request portal and at info@netec.org.
See the full press release.
###
WORD COUNT: 551
MEDIA CONTACT: Lisa Stone, Senior Marketing Manager
Email: communications@netec.org
Phone: 571-235-3265 (Mobile)
ABOUT NETEC
Established in 2015 by the U.S. Department of Health and Human Services Office of the Administration for Strategic Preparedness and Response (ASPR) and the Centers for Disease Control and Prevention (CDC) following the successful treatment of Ebola patients in 2014, NETEC’s mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.
NETEC leverages the unique expertise, resources, and experience of regional partners and federal agencies to assess health care facility readiness, train providers, provide technical assistance and build a rapid research infrastructure to combat emerging special pathogens, building a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. Visit netec.org for more information.
]]>Since January 1, 2023, there have been a total of 12,569 suspected Mpox cases, including 581 suspected Mpox deaths (case fatality ratio: 4.6%), reported in the Democratic Republic of Congo (DRC).
The National Emerging Special Pathogens Training and Education Center (NETEC) offers support for U.S. health care agencies that encounter, or may encounter, a case of Mpox virus infection with free, ongoing guidance and resources. NETEC experts are available to provide free consultations and technical support services through NETEC’s online service request portal and at info@netec.org.
See the full press release.
###
WORD COUNT: 551
MEDIA CONTACT: Lisa Stone, Senior Marketing Manager
Email: communications@netec.org
Phone: 571-235-3265 (Mobile)
ABOUT NETEC
Established in 2015 by the U.S. Department of Health and Human Services Office of the Administration for Strategic Preparedness and Response (ASPR) and the Centers for Disease Control and Prevention (CDC) following the successful treatment of Ebola patients in 2014, NETEC’s mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.
NETEC leverages the unique expertise, resources, and experience of regional partners and federal agencies to assess health care facility readiness, train providers, provide technical assistance and build a rapid research infrastructure to combat emerging special pathogens, building a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. Visit netec.org for more information.
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever usually transmitted by ticks. It can also be contracted through contact with viraemic animal tissues (animal tissue where the virus has entered the bloodstream) during and immediately post-slaughter of animals. CCHF outbreaks constitute a threat to public health services as the virus can lead to epidemics, has a high case fatality ratio (10–40%), potentially results in hospital and health facility outbreaks, and is difficult to prevent and treat. CCHF is endemic in all of Africa, the Balkans, the Middle East and in Asia.
The disease was first described in the Crimean Peninsula in 1944 and given the name Crimean haemorrhagic fever. In 1969 it was recognized that the pathogen causing Crimean haemorrhagic fever was the same as that responsible for an illness identified in 1956 in the Congo Basin. The linkage of the two place names resulted in the current name for the disease and the virus (WHO).
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever usually transmitted by ticks. It can also be contracted through contact with viraemic animal tissues (animal tissue where the virus has entered the bloodstream) during and immediately post-slaughter of animals. CCHF outbreaks constitute a threat to public health services as the virus can lead to epidemics, has a high case fatality ratio (10–40%), potentially results in hospital and health facility outbreaks, and is difficult to prevent and treat. CCHF is endemic in all of Africa, the Balkans, the Middle East and in Asia.
The disease was first described in the Crimean Peninsula in 1944 and given the name Crimean haemorrhagic fever. In 1969 it was recognized that the pathogen causing Crimean haemorrhagic fever was the same as that responsible for an illness identified in 1956 in the Congo Basin. The linkage of the two place names resulted in the current name for the disease and the virus (WHO).
Humans can be contaminated by the bite of infected fleas, through direct contact with infected materials, or by inhalation. Plague can be a very severe disease in people, particularly in its septicaemic and pneumonic forms, with a case-fatality ratio of 30% - 100% if left untreated.
]]>Plague is an infectious disease caused by Yersinia pestis bacteria, usually found in small mammals and their fleas. The disease is transmitted between animals via their fleas and, as it is a zoonotic bacterium, it can also transmit from animals to humans.
Humans can be contaminated by the bite of infected fleas, through direct contact with infected materials, or by inhalation. Plague can be a very severe disease in people, particularly in its septicaemic and pneumonic forms, with a case-fatality ratio of 30% - 100% if left untreated.
The webinar follows a revision to the ANSI / AAMI PB70 (PB70) standards document that was released in early 2023. PB70 standards cover barrier performance and classification of gowns, protective apparel, and drapes intended for use in health care facilities.
During a recent webinar, experts in personal protective equipment (PPE) and infection prevention and control presented updates to liquid barrier protection standards for PPE to help health care personnel make informed decisions about the PPE in their facilities.
The webinar follows a revision to the ANSI / AAMI PB70 (PB70) standards document that was released in early 2023. PB70 standards cover barrier performance and classification of gowns, protective apparel, and drapes intended for use in health care facilities.
A panel of NETEC experts in emergency management, infection prevention, personal protective equipment, and pre-hospital care joined a fireside chat to discuss the role of health care personnel in planning and emergency response within a universal preparedness framework. Watch the fireside chat.
Universal preparedness is the concept of multi-sector, coordinated response planning for emergencies. Within the health care sector, universal preparedness requires integrating preparedness across all health system functions, fostering a continual state of readiness, and equipping health care providers with the knowledge, skills, and planning to respond to any event.
A panel of NETEC experts in emergency management, infection prevention, personal protective equipment, and pre-hospital care joined a fireside chat to discuss the role of health care personnel in planning and emergency response within a universal preparedness framework. Watch the fireside chat.
Universal preparedness is the concept of multi-sector, coordinated response planning for emergencies. Within the health care sector, universal preparedness requires integrating preparedness across all health system functions, fostering a continual state of readiness, and equipping health care providers with the knowledge, skills, and planning to respond to any event.
Travel Health Notices inform travelers and clinicians about current health issues that impact travelers’ health, like disease outbreaks, special events or gatherings, and natural disasters, in destinations around the world. See types of travel notices.
DASH is comprised of several modules which, taken together, can provide hospitals a holistic view of the supplies needed to address various types of incidents.
]]>The Disaster Available Supplies in Hospitals (DASH) Tool is an interactive tool that can help hospital emergency planners and supply chain staff estimate supplies that may need to be immediately available during various mass casualty incidents (MCI) and infectious disease emergencies based on hospital characteristics.
DASH is comprised of several modules which, taken together, can provide hospitals a holistic view of the supplies needed to address various types of incidents.
People with mpox who do not require hospitalization should be isolated at home.
See this resource for information on Isolation of People with Mpox, Hand Hygiene, Source Control, and Personal Protective Equipment, and Household Disinfection.
The following resource was developed and shared during the multi-country Mpox outbreak of clade II in 2022-2023. The current outbreak of Mpox clade I requires different considerations for patient management as clade I is considered a select agent. If you have questions related to the isolation of patients and waste management, please reach out to us here or email us at info@netec.org.
People with mpox who do not require hospitalization should be isolated at home.
See this resource for information on Isolation of People with Mpox, Hand Hygiene, Source Control, and Personal Protective Equipment, and Household Disinfection.
To ensure the safety of your colleagues, you must lead, protect, and guide others through the process of safely and correctly donning and doffing PPE.
As a Trained Observer, you are responsible for:
To ensure the safety of your colleagues, you must lead, protect, and guide others through the process of safely and correctly donning and doffing PPE.
As a Trained Observer, you are responsible for:
PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES
SECTION I - INFECTIOUS AGENTWhat this is for: To provide detailed step by step procedures for use with the CDC guidance on Ebola-Associated Waste Management.
]]>Who this if for: Hospital infection control, occupational health systems, and facility medical waste managers and personnel
What this is for: To provide detailed step by step procedures for use with the CDC guidance on Ebola-Associated Waste Management.
What this is for: To provide recommendations for workers on the types of personal protective equipment (PPE) to be used and proper hygiene for the safe handling of untreated sewage that may contain Ebola virus.
How to use: Use this document to reduce the workers’ risk of exposure to infectious agents including Ebola virus when working with untreated sewage.
]]>Who this is for: Workers who handle untreated sewage that comes from hospitals, medical facilities, and other facilities with confirmed individuals with Ebola.
What this is for: To provide recommendations for workers on the types of personal protective equipment (PPE) to be used and proper hygiene for the safe handling of untreated sewage that may contain Ebola virus.
How to use: Use this document to reduce the workers’ risk of exposure to infectious agents including Ebola virus when working with untreated sewage.
Who this is for: State and local health departments and acute care hospitals designated as Ebola treatment centers.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans to serve as Ebola treatment centers.
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts by state and local health departments and healthcare facilities to prepare Ebola treatment centers, and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) or Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Assessment Hospitals and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation (PUIs) for Ebola Virus Disease.
Who this is for: State and local health departments and acute care hospitals designated as Ebola treatment centers.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans to serve as Ebola treatment centers.
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts by state and local health departments and healthcare facilities to prepare Ebola treatment centers, and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) or Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Assessment Hospitals and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation (PUIs) for Ebola Virus Disease.
Who this is for: State and local health departments and acute care hospitals that may serve as Ebola assessment hospitals.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans for patients under investigation (PUIs) for Ebola virus disease (EVD).
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts to prepare hospitals identified as Ebola assessment hospitals and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) and Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Treatment Centers and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation for Ebola Virus Disease.
Who this is for: State and local health departments and acute care hospitals that may serve as Ebola assessment hospitals.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans for patients under investigation (PUIs) for Ebola virus disease (EVD).
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts to prepare hospitals identified as Ebola assessment hospitals and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) and Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Treatment Centers and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation for Ebola Virus Disease.
Who this is for: State and local health departments and frontline healthcare facilities (acute care hospitals, and other emergency care settings including urgent care clinics, and critical access hospitals). This guidance does not address Ebola preparedness for primary care offices and other non-emergent ambulatory care settings.
What this is for: Guidance to assist frontline healthcare facilities and state and local health departments develop preparedness plans for patients under investigation (PUIs) for Ebola virus disease (EVD).
How this relates to other guidance documents/purpose: This guidance provides specific recommendations for frontline healthcare facilities and state and local health departments as they develop Ebola preparedness plans. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients under Investigation and with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this document complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Assessment Hospitals and Interim Guidance for Preparing Ebola Treatment Centers.
Who this is for: State and local health departments and frontline healthcare facilities (acute care hospitals, and other emergency care settings including urgent care clinics, and critical access hospitals). This guidance does not address Ebola preparedness for primary care offices and other non-emergent ambulatory care settings.
What this is for: Guidance to assist frontline healthcare facilities and state and local health departments develop preparedness plans for patients under investigation (PUIs) for Ebola virus disease (EVD).
How this relates to other guidance documents/purpose: This guidance provides specific recommendations for frontline healthcare facilities and state and local health departments as they develop Ebola preparedness plans. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients under Investigation and with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this document complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Assessment Hospitals and Interim Guidance for Preparing Ebola Treatment Centers.
Key Features
With the NIOSH PPE Tracker app, you can
The NIOSH PPE Tracker mobile app can help healthcare and non-healthcare systems track their personal protective equipment (PPE) inventory. Facilities can use the app to calculate their average PPE consumption rate or “burn rate.” The app estimates how many days a PPE supply will last given current inventory levels and PPE burn rate. Based on the PPE Burn Rate Calculator Excel spreadsheet, the app features several improvements, including an easy-to-use interface and the ability to add restock.
The app is available for both iOS and Android devices.
Key Features
With the NIOSH PPE Tracker app, you can
Join your colleagues in EMS, law enforcement, and healthcare from around the nation for our first-of-its-kind program based on real cases and situations generated by COVID-19. Learn techniques to manage self-care and increase resiliency and capacity during this crisis. Share best practices and receive support from peers, physicians, and mental health experts.
Designed by leading health experts at the University of Nebraska Medical Center, the 1-Check COVID app features an easy to use interface that asks you to complete a series of questions about your symptoms, travel, medical conditions, and exposure. Your assessment responses and results remain securely stored on your iOS device. Upon completion of the screening survey, you will be given an option to share your results with your healthcare provider, clinic, employer, public health service or others.
Results can be shared using a variety of formats including email, text message, and AirDrop.
Features:
-Actionable: provides clear guidance based on self-reported symptoms, travel, medical conditions, and exposure.
-High-fidelity: designed and tested by internationally recognized healthcare providers and researchers at the University of Nebraska Medical Center.
-User-friendly: easy to use interface allows for multiple profiles and screenings from a single device.
Designed by leading health experts at the University of Nebraska Medical Center, the 1-Check COVID app features an easy to use interface that asks you to complete a series of questions about your symptoms, travel, medical conditions, and exposure. Your assessment responses and results remain securely stored on your iOS device. Upon completion of the screening survey, you will be given an option to share your results with your healthcare provider, clinic, employer, public health service or others.
Results can be shared using a variety of formats including email, text message, and AirDrop.
Features:
-Actionable: provides clear guidance based on self-reported symptoms, travel, medical conditions, and exposure.
-High-fidelity: designed and tested by internationally recognized healthcare providers and researchers at the University of Nebraska Medical Center.
-User-friendly: easy to use interface allows for multiple profiles and screenings from a single device.
This repository is meant for clinicians (and not the general public) to access clinical and patient management information regarding COVID-19 that supplements their own independent, professional judgment, and evaluation of their institution’s unique circumstances (AAMC COVID-19 Clinical Guidance Repository Disclaimer).
]]>The AAMC COVID-19 Clinical Guidance Repository includes content from academic medical centers (AMCs) as a resource for hospitals and clinicians across the United States. The goal is to identify, summarize, and highlight areas of alignment in clinical practice during the pandemic. Here you will find up to date COVID-19 treatment and management guidance to help clinicians optimize patient care. Clinicians can view, access, and download clinical guidance that has been collected from AMCs.
This repository is meant for clinicians (and not the general public) to access clinical and patient management information regarding COVID-19 that supplements their own independent, professional judgment, and evaluation of their institution’s unique circumstances (AAMC COVID-19 Clinical Guidance Repository Disclaimer).
Qventus works with leading health systems across the country to improve operations and drive more efficient patient flow. Over recent weeks, they have been helping their partners with COVID-19 planning and preparation, including adapting the CDC Flu Surge model to COVID-19 and running it for key metropolitan areas and all states.
They’re sharing the information at the link with the hope that health systems find it informative as they plan for the impact of COVID-19. This analysis is preliminary, and they will continue to refine it as they get more information.
]]>Qventus works with leading health systems across the country to improve operations and drive more efficient patient flow. Over recent weeks, they have been helping their partners with COVID-19 planning and preparation, including adapting the CDC Flu Surge model to COVID-19 and running it for key metropolitan areas and all states.
They’re sharing the information at the link with the hope that health systems find it informative as they plan for the impact of COVID-19. This analysis is preliminary, and they will continue to refine it as they get more information.
Discrete-time SIR modeling of infections/recovery
The model consists of individuals who are either Susceptible, Infected, or Recovered.
The epidemic proceeds via a growth and decline process. This is the core model of infectious disease spread and has been in use in epidemiology for many years.
]]>Discrete-time SIR modeling of infections/recovery
The model consists of individuals who are either Susceptible, Infected, or Recovered.
The epidemic proceeds via a growth and decline process. This is the core model of infectious disease spread and has been in use in epidemiology for many years.
Nextstrain is incorporating nCoV genomes as soon as they are shared and providing analyses and situation reports. Please see below for the latest updates.
]]>Nextstrain is incorporating nCoV genomes as soon as they are shared and providing analyses and situation reports. Please see below for the latest updates.
Available in spanish (Español) on the linked page.
User Seal Check Procedures (Mandatory)
Who this is for: Hospitals and healthcare providers that care for patients under investigation (PUIs) for Ebola virus disease (EVD) or with confirmed cases of EVD.
What this is for: To help hospitals and healthcare providers safely handle, transport, and dispose of waste generated by the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).
How to use: This guidance is intended to provide key information about procedures and regulations regarding waste associated with the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).
]]>Who this is for: Hospitals and healthcare providers that care for patients under investigation (PUIs) for Ebola virus disease (EVD) or with confirmed cases of EVD.
What this is for: To help hospitals and healthcare providers safely handle, transport, and dispose of waste generated by the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).
How to use: This guidance is intended to provide key information about procedures and regulations regarding waste associated with the care of patients under investigation (PUIs) for or with confirmed Ebola virus disease (EVD).
Nextstrain is an open-source project to harness the scientific and public health potential of pathogen genome data. Datasets are available on ebola, flu, enterovirus, WNV, tb, lassa, mumps, zikka, dengue, and measles.